Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Bex

Showing results (31-40 of 331) with videos related to

Pageof 34
Sort By:
European Urology|December 3, 2015
Comparing Everolimus to Sunitinib in Non-clear-cell Renal Cell CarcinomaAxel Bex, Börje Ljungberg
European Urology Oncology|December 4, 2025
Assessment of Pathologic Response in Kidney Cancer: Back to the Microscope for NowAxel Bex, Grant D Stewart
Current Oncology Reports|February 8, 2011
Non-clear cell renal cell carcinoma: how new biological insight may lead to new therapeutic modalitiesAxel Bex, James Larkin, Christian Blank
Cardiovascular and Interventional Radiology|October 21, 2011
Percutaneous radiofrequency ablation of a small renal mass complicated by appendiceal perforationJudith Boone, Axel Bex, Warner Prevoo
The New England Journal of Medicine|November 9, 2018
Sunitinib Alone or after Nephrectomy in Renal CancerAxel Bex, Thomas Powles, John Haanen
European Urology|March 30, 2019
Re: Paul C.M.S. Verhagen, Egbert R. Boevé. The European Association of Urology Guideline on Renal Cell Carcinoma (RCC) is Not Concise in its Recommendation to Perform Partial Nephrectomy in T1b RCC. Eur Urol 2019:76:136-7Lorenzo Marconi, Karim Bensalah, Axel Bex, et al.
Current Opinion in Urology|July 30, 2016
Metastasis therapies for renal cancerSaeed Dabestani, Lorenzo Marconi, Axel Bex
Urology|September 5, 2017
Author ReplyRoderick E de Bruijn, Axel Bex
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Challenging the treatment paradigm for advanced renal cell carcinoma: a review of systemic and localized therapiesAxel Bex, James Larkin, Martin Voss
Current Opinion in Urology|March 26, 2021
Editorial: Standard and future in the treatment of renal cell carcinomaJens Bedke, Axel Bex, Manuela Schmidinger
Pageof 34

Showing results (31-40 of 331) with videos related to

Sort By:
Pageof 34
European Urology|December 3, 2015
Comparing Everolimus to Sunitinib in Non-clear-cell Renal Cell CarcinomaAxel Bex, Börje Ljungberg
European Urology Oncology|December 4, 2025
Assessment of Pathologic Response in Kidney Cancer: Back to the Microscope for NowAxel Bex, Grant D Stewart
Current Oncology Reports|February 8, 2011
Non-clear cell renal cell carcinoma: how new biological insight may lead to new therapeutic modalitiesAxel Bex, James Larkin, Christian Blank
Cardiovascular and Interventional Radiology|October 21, 2011
Percutaneous radiofrequency ablation of a small renal mass complicated by appendiceal perforationJudith Boone, Axel Bex, Warner Prevoo
The New England Journal of Medicine|November 9, 2018
Sunitinib Alone or after Nephrectomy in Renal CancerAxel Bex, Thomas Powles, John Haanen
European Urology|March 30, 2019
Re: Paul C.M.S. Verhagen, Egbert R. Boevé. The European Association of Urology Guideline on Renal Cell Carcinoma (RCC) is Not Concise in its Recommendation to Perform Partial Nephrectomy in T1b RCC. Eur Urol 2019:76:136-7Lorenzo Marconi, Karim Bensalah, Axel Bex, et al.
Current Opinion in Urology|July 30, 2016
Metastasis therapies for renal cancerSaeed Dabestani, Lorenzo Marconi, Axel Bex
Urology|September 5, 2017
Author ReplyRoderick E de Bruijn, Axel Bex
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Challenging the treatment paradigm for advanced renal cell carcinoma: a review of systemic and localized therapiesAxel Bex, James Larkin, Martin Voss
Current Opinion in Urology|March 26, 2021
Editorial: Standard and future in the treatment of renal cell carcinomaJens Bedke, Axel Bex, Manuela Schmidinger
Pageof 34